Results 191 to 200 of about 106,112 (301)

Prognostic Factors and Clinical Prediction Score for Progressive Respiratory Failure in Severe COVID-19 Pneumonia Patients Treated with Tocilizumab: A Multicenter Study. [PDF]

Ther Clin Risk Manag
Pongtarakulpanit N, Jayanama K, Phinyo P, Naothavorn W, Nuprom S, Pitidhammabhorn D, Ngammisri P, Ngamjanyaporn P, Suthichatchawan V, Wicharit L, Thammavaranucupt K.   +10 more
europepmc   +1 more source

The Association Between Serum Immunoglobulin G Titers Against Porphyromonas gingivalis and Chronic Kidney Disease in Patients With Rheumatoid Arthritis and Periodontitis: A Retrospective Cohort Study

Clinical and Experimental Dental Research, Volume 12, Issue 1, February 2026.
ABSTRACT Objectives Chronic kidney disease (CKD) is relatively common in patients with rheumatoid arthritis (RA). Periodontitis and periodontopathic Porphyromonas gingivalis are risk factors for CKD. However, the association of serum immunity to P. gingivalis and its peptidylarginine deiminase (PPAD), as well as periodontitis severity, with CKD in ...
Tetsuo Kobayashi, Satoshi Ito, Noriko Sugita, Akira Murasawa, Hajime Ishikawa, Koichi Tabeta   +5 more
wiley   +1 more source

Refractory Macrophage Activation Syndrome in a Patient with Systemic Lupus Erythematosus Treated with Tocilizumab

, 2015
Jin Sun Oh, Jinoh Park, Nah Kyum Lee, Seung‐Hyeon Bae, Yong‐Gil Kim, Chang‐Keun Lee, Bin Yoo   +6 more
openalex   +1 more source

AB093. SOH22ABS006. Evidence for the efficacy of tocilizumab in hospitalised patients with coronavirus disease 2019 (COVID-19): a structured review of the literature

, 2022
Laura Kennedy, Paul Mallee, Catherine Nix   +2 more
openalex   +1 more source

Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis. [PDF]

Rheumatology (Oxford)
Goldman NR, Nihtyanova SI, Beesley CF, Wells AU, Denton CP, Renzoni EA, Mageed R, Ong VH.   +7 more
europepmc   +1 more source

Outcome of severe to critical COVID-19 patients with tocilizumab therapy

M. Tanimul Haque Rijvy, M. Shariful Alam, Uma Dhar, Abir Hasan Dip, Shaiful Azam Quadry, Hosneara Parvin, Shilpy Akter, Mohammad Ashrafuzzaman, Samprity Islam, Arif Hossain   +9 more
openalex   +2 more sources

Experience of using tocilizumab for treatment in Indonesian patients with severe COVID-19

, 2020
Allen Widysanto, Andree Kurniawan, Nata Pratama Hardjo Lugito, Mira Yuniarti, C. Gunawan, Angela Angela, Jessica Wiryanto, Levinna, Tasya Meidy Pradhana   +8 more
openalex   +2 more sources

Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive Cohort

eJHaem, Volume 7, Issue 1, February 2026.
ABSTRACT Introduction Real‐world data on teclistamab in relapsed or refractory multiple myeloma (R/R MM), particularly in elderly patients, remain limited. Methods We analysed efficacy and safety outcomes in patients ≥ 75 years from the French RetrosTECtive cohort.
A. Coste, S. Godet, S. Manier, J. R. Eveillard, C. Croizier, C. Mariette, C. Breal, H. Manjra, C. Touzeau, M. Mohty, R. Belkhir, A. Bobin, A. Lévêque, B. Cherel, L. Montes, F. Orsini‐Piocelle, L. Frenzel, D. Robu, E. Chalayer, S. Harel, L. Vincent, L. Bauschert, A. Dony, R. Tabrizi, P. Moreau, C. Hulin, A. Perrot   +26 more
wiley   +1 more source

Interleukin-6 Inhibitor-Induced Leukocytoclastic Vasculitis: A Case Report With a Literature Review. [PDF]

Case Reports Immunol
Aloyan T, Salimova D, Mohamed E, Wazir H.   +3 more
europepmc   +1 more source

Clinical Outcomes Following Tocilizumab Administration in Mechanically Ventilated Coronavirus Disease 2019 Patients

, 2020
Michael Sirimaturos, Deepa Gotur, Samir J. Patel, Diane Dreucean, Nicholas Jakowenko, Megan H. Cooper, Nishal Brahmbhatt, Edward A. Graviss, Duc T. Nguyen, Sai Ravi Pingali, Jiejian Lin, William L. Musick   +11 more
openalex   +1 more source